Actively Recruiting

Phase 4
Age: 5Years - 14Years
All Genders
NCT06465576

Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)

Led by University of Aarhus · Updated on 2025-12-15

216

Participants Needed

5

Research Sites

183 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary objective is to investigate if abrupt withdrawal versus gradual withdrawal of pharmacotherapy (solifenacin and/or mirabegron) influences the risk of recurrence of incontinence. Children aged 5-14 years diagnosed with urinary incontinence, treated with pharmacotherapy of solifenacin and/or mirabegron and ready for withdrawal will be randomized 1:1 to either abrupt or gradual withdrawal, according to the medical treatment that the child is receiving.

CONDITIONS

Official Title

Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)

Who Can Participate

Age: 5Years - 14Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • The participant's custody holder(s) must voluntarily sign and date an informed consent before starting any study procedures.
  • Child aged 5 to 14 years at the time of consent and inclusion.
  • Diagnosed with urinary incontinence according to ICCS criteria.
  • Currently treated with solifenacin and/or mirabegron.
  • Continence achieved while on solifenacin and/or mirabegron therapy.
  • Previous withdrawal attempts are allowed.
  • Continence maintained on the same medication dose for at least three months.
Not Eligible

You will not qualify if you...

  • Inability of the participant or parental custody holder to understand written and spoken Danish.
  • Presence of neurogenic detrusor overactivity (neurogenic bladder).

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

Department of Pediatric and Adolescent Medicine, Aalborg University Hospital

Aalborg, Aalborg, Denmark, 9000

Actively Recruiting

2

Department of Pediatric and Adolescent Medicine, Aarhus University Hospital

Aarhus, Aarhus N, Denmark, 8200

Actively Recruiting

3

Department of Pediatric and Adolescent medicine, Esbjerg Hospital

Esbjerg, Esbjerg, Denmark, 6700

Not Yet Recruiting

4

Department of Pediatric and Adolescent Medicine, Gødstrup Hospital

Herning, Herning, Denmark, 7400

Actively Recruiting

5

Department of Pediatric and Adolescent Medicine, Kolding Hospital

Kolding, Kolding, Denmark, 6000

Not Yet Recruiting

Loading map...

Research Team

A

Ann-Kristine Mandøe Svendsen, MD

CONTACT

L

Luise Borch, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

6

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here